A detailed history of Eversept Partners, LP transactions in Natera, Inc. stock. As of the latest transaction made, Eversept Partners, LP holds 870,193 shares of NTRA stock, worth $141 Million. This represents 8.75% of its overall portfolio holdings.

Number of Shares
870,193
Previous 1,173,494 25.85%
Holding current value
$141 Million
Previous $127 Million 12.97%
% of portfolio
8.75%
Previous 9.6%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$97.75 - $129.67 $29.6 Million - $39.3 Million
-303,301 Reduced 25.85%
870,193 $111 Million
Q2 2024

Aug 14, 2024

SELL
$85.28 - $112.6 $51.6 Million - $68.1 Million
-604,557 Reduced 34.0%
1,173,494 $127 Million
Q1 2024

May 15, 2024

SELL
$59.21 - $92.9 $28 Million - $44 Million
-473,537 Reduced 21.03%
1,778,051 $163 Million
Q4 2023

Feb 14, 2024

SELL
$37.55 - $62.64 $9.05 Million - $15.1 Million
-241,048 Reduced 9.67%
2,251,588 $141 Million
Q3 2023

Nov 14, 2023

BUY
$43.4 - $62.52 $3.42 Million - $4.93 Million
78,849 Added 3.27%
2,492,636 $110 Million
Q2 2023

Nov 08, 2023

SELL
$47.08 - $55.16 $19.1 Million - $22.4 Million
-405,983 Reduced 14.4%
2,413,787 $117 Million
Q2 2023

Aug 14, 2023

SELL
$47.08 - $55.16 $19.1 Million - $22.4 Million
-405,983 Reduced 14.4%
2,413,787 $117 Million
Q1 2023

Nov 08, 2023

BUY
$36.57 - $58.29 $4.89 Million - $7.8 Million
133,811 Added 4.98%
2,819,770 $157 Million
Q1 2023

May 15, 2023

BUY
$36.57 - $58.29 $4.89 Million - $7.8 Million
133,811 Added 4.98%
2,819,770 $157 Million
Q4 2022

Nov 08, 2023

BUY
$34.17 - $47.91 $43.1 Million - $60.4 Million
1,260,357 Added 88.41%
2,685,959 $108 Million
Q4 2022

Feb 14, 2023

BUY
$34.17 - $47.91 $43.1 Million - $60.4 Million
1,260,357 Added 88.41%
2,685,959 $108 Million
Q3 2022

Nov 08, 2023

BUY
$36.93 - $56.68 $35.1 Million - $53.8 Million
949,947 Added 199.71%
1,425,602 $62.5 Million
Q3 2022

Nov 14, 2022

BUY
$36.93 - $56.68 $35.1 Million - $53.8 Million
949,947 Added 199.71%
1,425,602 $62.5 Million
Q2 2022

Nov 08, 2023

SELL
$28.13 - $44.54 $54.5 Million - $86.3 Million
-1,938,132 Reduced 80.29%
475,655 $16.9 Million
Q2 2022

Aug 15, 2022

BUY
$28.13 - $44.54 $13.4 Million - $21.2 Million
475,655 New
475,655 $16.9 Million
Q1 2022

May 16, 2022

SELL
$30.32 - $91.33 $3.09 Million - $9.32 Million
-102,071 Closed
0 $0
Q4 2021

Nov 08, 2023

SELL
$86.26 - $119.0 $872,778 - $1.2 Million
-10,118 Reduced 9.02%
102,071 $9.53 Million
Q4 2021

Feb 14, 2022

SELL
$86.26 - $119.0 $872,778 - $1.2 Million
-10,118 Reduced 9.02%
102,071 $9.53 Million
Q3 2021

Nov 08, 2023

BUY
$100.17 - $126.36 $10.3 Million - $13 Million
102,875 Added 1104.52%
112,189 $12.5 Million
Q3 2021

Nov 15, 2021

BUY
$100.17 - $126.36 $10.3 Million - $13 Million
102,875 Added 1104.52%
112,189 $12.5 Million
Q2 2021

Nov 08, 2023

SELL
$86.05 - $119.72 $4.16 Million - $5.79 Million
-48,386 Reduced 83.86%
9,314 $1.06 Million
Q2 2021

Aug 16, 2021

SELL
$86.05 - $119.72 $4.16 Million - $5.79 Million
-48,386 Reduced 83.86%
9,314 $1.06 Million
Q1 2021

Nov 08, 2023

SELL
$91.47 - $124.36 $216 Million - $293 Million
-2,356,087 Reduced 97.61%
57,700 $5.86 Million
Q1 2021

May 13, 2021

BUY
$91.47 - $124.36 $5.28 Million - $7.18 Million
57,700 New
57,700 $5.86 Million
Q1 2020

May 13, 2020

SELL
$17.27 - $40.17 $2.71 Million - $6.31 Million
-157,081 Closed
0 $0
Q4 2019

Nov 08, 2023

BUY
$32.1 - $40.4 $3.77 Million - $4.75 Million
117,542 Added 297.28%
157,081 $5.29 Million
Q4 2019

Feb 13, 2020

BUY
$32.1 - $40.4 $5.04 Million - $6.35 Million
157,081 New
157,081 $5.29 Million
Q1 2019

May 14, 2019

SELL
$11.34 - $20.62 $448,372 - $815,294
-39,539 Closed
0 $0
Q4 2018

Nov 08, 2023

SELL
$12.32 - $24.38 $29.3 Million - $57.9 Million
-2,374,248 Reduced 98.36%
39,539 $551,000
Q4 2018

Feb 13, 2019

BUY
$12.32 - $24.38 $487,120 - $963,960
39,539 New
39,539 $552,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.